Abstract:With the rapid development of the fields of tumor biology and immunology, tumor immunotherapy has been used in clinical practice and has demonstrated significant therapeutic potential, particularly for treating tumors that do not respond to standard treatment options. Despite its advances, immunotherapy still has limitations, such as poor clinical response rates and differences in individual patient responses, largely because tumor tissues have strong immunosuppressive microenvironments. Many tumors have a tumor microenvironment (TME) that is characterized by hypoxia, low pH, and substantial numbers of immunosuppressive cells, and these are the main factors limiting the efficacy of antitumor immunotherapy. The TME is crucial to the occurrence, growth, and metastasis of tumors. Therefore, numerous studies have been devoted to improving the effects of immunotherapy by remodeling the TME. Effective regulation of the TME and reversal of immunosuppressive conditions are effective strategies for improving tumor immunotherapy. The use of multidrug combinations to improve the TME is an efficient way to enhance antitumor immune efficacy. However, the inability to effectively target drugs decreases therapeutic effects and causes toxic side effects. Nanodrug delivery carriers have the advantageous ability to enhance drug bioavailability and improve drug targeting. Importantly, they can also regulate the TME and deliver large or small therapeutic molecules to decrease the inhibitory effect of the TME on immune cells. Therefore, nanomedicine has great potential for reprogramming immunosuppressive microenvironments and represents a new immunotherapeutic strategy. Therefore, this article reviews strategies for improving the TME and summarizes research on synergistic nanomedicine approaches that enhance the efficacy of tumor immunotherapy. Graphical Download : Download high-res image (225KB) Download : Download full-size image Overview of strategies for reshaping the tumor microenvironment and improving the efficacy of immunotherapy based on nanomedicine and nanodelivery systems.

Modulating the tumor microenvironment with new therapeutic nanoparticles: A promising paradigm for tumor treatment

Modulating the Tumor Microenvironment to Enhance Tumor Nanomedicine Delivery

Nanoparticles Targeting and Remodeling Tumor Microenvironment for Cancer Theranostics.

“Smart” Nanocarriers: A New Paradigm for Tumor Targeting Drug Delivery Systems

Anticancer nanomedicines harnessing tumor microenvironmental components

Tumor Microenvironment Regulation and Cancer Targeting Therapy Based on Nanoparticles

Advances in Nanoplatforms for Immunotherapy Applications Targeting the Tumor Microenvironment

Nanotherapy Targeting the Tumor Microenvironment

Modulating Tumor Mechanics with Nanomedicine for Cancer Therapy

Tumor Microenvironment‐Enabled Nanotherapy

Tumor microenvironment reprogramming by nanomedicine to enhance the effect of tumor immunotherapy

Engineered Nanomaterials for Tumor Immune Microenvironment Modulation in Cancer Immunotherapy

Nanoparticles for Modulating Tumor Microenvironment to Improve Drug Delivery and Tumor Therapy

Tumor Microenvironment Modulating Functional Nanoparticles for Effective Cancer Treatments

Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy

The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment

Recent Advances in Nanomodulators for Augmenting Cancer Immunotherapy in Cold Tumors: Insights from Drug Delivery to Drug‐Free Strategies

Biochemical hallmarks-targeting antineoplastic nanotherapeutics

Overcoming tumor microenvironment obstacles: Current approaches for boosting nanodrug delivery

Tumor Therapy Strategies Based on Microenvironment‐Specific Responsive Nanomaterials

Nanotherapeutic approaches targeting angiogenesis and immune dysfunction in tumor microenvironment